The Early Breast Cancer Trialists ́ Collaborative Group (Peto et al. 2012) demonstrated that the effect of chemotherapy was independent of age, node status, tumor size, differentiation, ER-status, and tamoxifen use. Here, ESR1 is linked to breast cancer.